How conquering a rare leukemia in children revolutionized cancer care for millions

"That success story — one with deep Philadelphia roots — is even more phenomenal than it sounds. While ALL accounts for almost a third of pediatric cancers, it is a rare cancer overall, with about 2,900 annual diagnoses in the United States. Yet this uncommon malignancy is the tie that binds giants of oncology research, scientific breakthroughs, revolutionary drugs, and startling philanthropy, not to mention a Pulitzer Prize-winning book that became an acclaimed PBS documentary series."

Read more: https://www.inquirer.com/health/acute-lymphoblastic-leukemia-cancer-immunotherapy-farber-pinkel-whitehead-carl-june-20190605.html